Sharemaestro Newsreel

Merit Medical Systems Stock Climbs 25% On A 13-Day Winning Streak

Merit Medical Systems (MMSI) stock has surged 25% over 13 consecutive trading days, adding $1.1 billion to its market value and bringing its total valuation to $5.4 billion. This impressive streak significantly outperforms the S&P 500's 4.3% gain over the same period, suggesting company-specific …

Intuitive surgical director Amy Ladd sells $179,903 in company stock

Amy L. Ladd, a director at Intuitive Surgical Inc. (NASDAQ:ISRG), recently sold shares totaling $179,903 in August 2026 under a pre-arranged trading plan. Following these transactions, Ms. Ladd directly holds 179 shares. This news follows Intuitive Surgical's strong second-quarter results but also highlights mixed …

ICU Medical Inc (ICUI) Insider Sell: Christian Voigtlander Disposes of 8,929 Shares

Christian Voigtlander, an insider at ICU Medical Inc (ICUI), recently sold 8,929 shares for approximately $1.63 million, reducing his direct ownership to 37,377 shares. This sale contributes to a trend of more insider selling than buying at ICUI over the past year (8 sells …

Intuitive Surgical (ISRG) Director Amy Ladd Sells 472 Shares

Intuitive Surgical (ISRG) Director Amy Ladd sold 472 shares on August 11, 2026, totaling approximately $179,903, reducing her stake by over 72%. This sale is part of a larger trend of insider selling at the company, with 41 insider sells and no buys over …

Why Merit Medical Systems (MMSI) Is Up 14.4% After Raising 2026 Revenue Outlook And Margins

Merit Medical Systems (MMSI) saw its stock rise by 14.4% after reporting strong Q2 2026 results and raising its full-year 2026 revenue outlook to US$1.631 billion–US$1.643 billion. This positive revision is attributed to better-than-expected first-half performance, recent acquisitions, and efficiency gains. While the raised …

Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments

Alcon (SIX/NYSE:ALC) reported strong financial results for Q2 2026, with net sales reaching $2.8 billion, an 8 percent increase year-over-year. Both its Vision Care and Surgical segments contributed to this growth, driven by product innovation and strategic collaborations. The company also updated its full-year …

1 Unpopular Stock That Deserves Some Love and 2 We Avoid

1 Unpopular Stock That Deserves Some Love and 2 We Avoid Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth. Whatever …

Femasys COO John Canning buys $14,000 in FEMY stock By Investing.com

John Canning, COO of Femasys Inc. (NASDAQ: FEMY), recently purchased 4,375 shares of company stock for $14,000 at $3.20 per share, along with two types of warrants. This transaction occurred while FEMY stock trades near its 52-week low, and InvestingPro analysis suggests the stock …

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

Sanara MedTech Inc. announced its financial results for the second quarter and first six months of 2026, reporting increased net revenue and gross profit. The company's net revenue rose 9% to $28.1 million in Q2 2026 and 14% to $55.9 million for the first …

Femasys chief clinical-medical affairs Mifek buys $10,000 stock

Jeffrey Gerald Mifek, Chief Clinical-Medical Affairs at Femasys Inc. (NASDAQ:FEMY), recently purchased $10,000 worth of common stock and acquired two warrants. The stock purchase was at $3.20 per share, above the current trading price, with one warrant exercisable soon and another tied to significant …

Is Recall-Hit Outlook and Bigger Payout Altering The Investment Case For ResMed (RMD)?

In early August 2026, ResMed reported past fourth-quarter and full-year results showing higher sales and earnings, announced a 10% increase in its quarterly US$0.66 dividend, and confirmed completion of a long-running US$1.40 billions share buyback program. At the same time, management issued a softer …

EMBC 6-DAY DEADLINE ALERT: Embecta Corp. Investors with

Hagens Berman is investigating Embecta Corp. (NASDAQ: EMBC) for alleged federal securities law violations after a class action lawsuit was filed. The lawsuit claims Embecta misrepresented the stability of its insulin pen needle business, leading to substantial investor losses. Investors who suffered losses between …

Femasys Raises $30 Million in Private Placement; Adds Investor Board Rights, Ends Prior Nomination Rights

Femasys (FEMY) has completed a $30 million private placement of common stock and warrants to strengthen liquidity and fund growth. The agreement also includes registration rights for investors and grants Nantahala Capital Management board representation based on ownership thresholds. Concurrently, previous board nomination and …

Alcon Earnings: Unity Performance Continues to Impress and Makes Up for Soft Lens Market

Alcon reported strong second-quarter results with 9% revenue growth and 10% core EPS growth, both exceeding FactSet consensus. The company also raised its guidance for operating margin and EPS by 200 basis points, leading to a 2% increase in shares. The impressive performance of …

Femasys CTO Jeremy Sipos buys $10,000 in common stock

Femasys CTO Jeremy Sipos recently purchased $10,000 worth of common stock and acquired two types of warrants, each allowing for the purchase of 3,125 shares. This transaction occurred as the stock trades near its 52-week low. The company has also regained Nasdaq compliance and …

Femasys CEO Kathy Lee-Sepsick buys $50,000 in FEMY stock

Femasys CEO Kathy Lee-Sepsick purchased 15,625 shares of FEMY stock for $50,000, along with two types of warrants, indicating confidence in the company, especially as the stock trades near its 52-week low. This insider purchase follows recent positive developments for Femasys, including regaining Nasdaq …

Align Technology Prevails in China Patent Infringement Action Against Angelalign

SAN JOSE, Calif. & TEMPE, Ariz., August 12, 2026--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a …

Anteris Technologies advances PARADIGM Trial in June quarter as US patient recruitment gets underway

Anteris Technologies made significant progress in its PARADIGM Trial during the June quarter, beginning US patient recruitment and expanding internationally. The company secured Medicare reimbursement eligibility for qualifying procedures in the US, facilitating patient enrollment. The trial, which compares Anteris' DurAVR® Transcatheter Heart Valve …

Icu medical director Elisha Finney sells $68,978 in stock

Elisha W. Finney, a director at ICU Medical Inc./DE (NASDAQ:ICUI), sold 378 shares of common stock for $68,978 on August 11, 2026. This transaction occurred as the stock neared its 52-week high, having returned 68% over the past year. Despite the sale, Finney still …

Icu medical COO Christian Voigtlander sells $1.63m in stock

ICU Medical COO Christian Voigtlander recently sold 8,929 shares of company stock for over $1.63 million, with transactions occurring on August 11, 2026, as the stock trades near its 52-week high. The company has shown strong financial performance, exceeding Q2 2026 expectations and raising …

Vaseem Mahboob Sells 26,287 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock

Kestra Medical Technologies CFO Vaseem Mahboob sold 26,287 shares of KMTS stock for over $680,000, reducing his direct holdings by 30.25%. This recent sale follows four earlier transactions in late July and early August. The company's stock fell 1.6%, and it reported a wider-than-expected …

Insider Selling: ICU Medical (NASDAQ:ICUI) COO Sells $1,633,381.97 in Stock

ICU Medical (NASDAQ:ICUI) COO Christian Voigtlander sold 8,929 shares of the company's stock for over $1.63 million, reducing his stake by 19.28%. This sale occurred after ICU Medical reported strong quarterly earnings, surpassing analyst expectations for both EPS and revenue, while maintaining its fiscal …

EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Embecta Corp. to Contact the Firm Today!

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Embecta Corp. (NASDAQ:EMBC) and its officers for alleged federal securities law violations. The firm encourages investors who purchased Embecta securities between November 25, 2025, and May 4, 2026, to contact them, as …

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Hellman & Friedman funds (MDLN) report 153M Medline Class A shares in latest ownership update

Hellman & Friedman-affiliated investment vehicles have updated their ownership report for Medline Inc., indicating beneficial ownership of 153,327,675 shares of Class A common stock as of June 30, 2026. This represents up to 16.0% of the class for certain entities and includes shares already …

ICU Medical (ICUI) COO sells 8,929 shares in open-market trade

ICU Medical Inc. (ICUI) Chief Operating Officer Christian B. Voigtlander sold 8,929 shares of common stock on August 11, 2026, at a weighted average price of $182.93 per share. This open-market transaction reduced his direct holdings to 37,377 shares. The sale amounted to approximately …

Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate

Intuitive Surgical (ISRG) Is Up 9.0% After Q2 Beat And Governance Shift Has The Bull Case Changed?

Intuitive Surgical (ISRG) reported strong Q2 2026 results, beating revenue and adjusted EPS forecasts, which led to a 9.0% stock increase. The company also updated its bylaws to align with SEC universal proxy requirements, affecting shareholder influence and board elections. While global procedure growth …

Kestra Medical Technologies (NASDAQ: KMTS) CFO trades 26,287 shares in 10b5-1 sales

Kestra Medical Technologies CFO Vaseem Mahboob sold 26,287 common shares of KMTS in two open-market transactions on August 7, 2026. These sales were conducted under a Rule 10b5-1 trading plan established on November 6, 2025. The shares were sold at weighted average prices of …

Sanara Medtech earnings missed by $0.02, revenue fell short of estimates

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost

Glancy Prongay Wolke & Rotter LLP has issued a deadline alert for investors of Embecta Corp. (EMBC) who suffered losses. Shareholders who purchased securities between November 25, 2025, and May 4, 2026, are urged to contact the firm regarding a securities fraud lawsuit, with …

Solventum Corp. stock falls Tuesday, underperforms market

Solventum Corp. (SOLV) shares dropped 1.30% to $84.10 on Tuesday, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also saw declines. This fall ended a two-day winning streak for the stock.

Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss

Sanara MedTech Inc. (SMTI) reported significant revenue growth for the first half of 2026, reaching $55.9 million, primarily driven by strong sales of its soft tissue repair products. The company also substantially reduced its net loss attributable to shareholders, nearly breaking even with a …

Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary

Sanara MedTech Inc. reported its Q2 2026 financial results, with revenue reaching $28.14M, a 9.1% increase year-over-year. The company posted a diluted loss per share of $(0.05), an improvement from $(0.23) in Q2 2025. This growth was primarily driven by surgical soft tissue repair …

Alcon Inc (ALC) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Strategic Pivots ...

This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Alcon Inc (NYSE:ALC) delivered 7% sales growth in Q2 2026, driven by broad-based strength across …